BenzingaAugust 5, 2026 at 12:39 PM NY2 Months Ago
Black Diamond Therapeutic Q2 EPS $(0.17) Beats $(0.19) Estimate
Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.19) by 10.53 percent. This is a 10.53 percent increase over losses of $(0.19) per
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
